Clinical Trials Browser

NCT01442649 2022-01-11

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Phase 2 Completed

133 enrolled

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT01442935 2021-06-18

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Phase 2 Completed

256 enrolled

Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT04739202 2021-03-29

IMMUNOGAST

Phase 2 Unknown

60 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT00847119 2017-08-29

xeberecto

Phase 2 Completed

43 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT00127036 2017-03-23

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Phase 2 Terminated

65 enrolled 8 charts

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Rectal Neoplasms

NCT00719264 2017-03-20

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase 2 Completed

365 enrolled 14 charts

Genitourinary

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

NCT00447330 2015-02-13

XAGastric

Phase 2 Completed

60 enrolled 9 charts

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT01554059 2014-11-10

New Beat

Phase 2 Completed

25 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT00600821 2013-11-08

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Phase 2 Completed

118 enrolled 12 charts

Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00597506 2012-12-27

BEV/EV

Phase 2 Completed

50 enrolled 7 charts

Tumor-Agnostic

Adenocarcinoma

NCT00226005 2012-05-09

PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma

Phase 2 Completed

67 enrolled

Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT01175291 2011-12-05

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms